WHCS.AS
iShares MSCI World Health Care Sector Advanced UCITS ETF
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 756.7 M
ASSETS UNDER MGMT
18 bp
EXPENSES
Fund Basics
| Inception date | Oct 17, 2019 |
| Regulation | UCITS |
| ISIN | IE00BJ5JNZ06 |
| Distributions | Semi-annual |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ELI LILLY & CO | 10.3 % |
| NOVARTIS AG | 5.1 % |
| JOHNSON & JOHNSON | 4.8 % |
| ABBVIE INC | 4.5 % |
| ASTRAZENECA PLC | 3.7 % |
| ROCHE HOLDING AG-BR | 3.5 % |
| UNITEDHEALTH GROUP INC | 3.5 % |
| MERCK & CO. INC. | 2.8 % |
| GILEAD SCIENCES INC | 2.7 % |
| NOVO NORDISK A/S-B | 2.5 % |
Constituent Breakdown
| Number of holdings | 152 |
| Herfindahl-Hirschman Index | 299 |
| Wgt avg mkt cap (mns) | $238,853 |
| Large cap (>$10bn) | 97.0% |
| Mid cap ($2-10bn) | 1.4% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 98.4% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 67.0 % |
 |
SWITZERLAND | 11.3 % |
 |
BRITAIN | 4.8 % |
 |
JAPAN | 4.0 % |
 |
DENMARK | 3.9 % |
 |
FRANCE | 1.9 % |
 |
IRELAND | 1.7 % |
 |
AUSTRALIA | 1.2 % |
 |
BELGIUM | 0.9 % |
 |
GERMANY | 0.7 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 2.6% | 11.8% | 3.3% | 5.9% | 5.4% | -- | -- | 7.7% |
| Dividend Yield | 0.0% | 1.3% | 1.1% | 1.2% | 1.2% | -- | -- | 1.2% |
| Total Returns | 2.6% | 13.1% | 4.3% | 7.1% | 6.5% | -- | -- | 8.9% | Ann. Volatility | 11.7% | 15.9% | 13.8% | 13.0% | 14.2% | -- | -- | 16.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | -0.01 | 0% |
| MSCI EAFE | 0.18 | 4% |
| MSCI Emg Mkts | 0.10 | 1% |
Liquidity Measures
| Avg. volume (000) | 19 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $7.95 |
| Relative strength (RSI) | 58 |
| MACD/Signal | 0.02/0.02 |
| Bollinger Bands (Upper/Lower) | $8.06/$7.87 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. WHCS.AS |
Expenses vs. WHCS.AS |
ALTAR Score™ vs. WHCS.AS |
|---|---|---|---|---|
| WHCA.L | iShares MSCI World Health Care Sector Advanced UCITS ETF | 98.4% | 0 bp | -0.3% |
| XDWH.DE | Xtrackers MSCI World Health Care UCITS ETF 1C | 74.2% | +7 bp | +0.1% |
| WELS.DE | Amundi S&P World Health Care Screened UCITS ETF Acc | 71.1% | 0 bp | 0.0% |
| WELG.DE | Amundi S&P World Health Care Screened UCITS ETF Dist | 71.1% | 0 bp | -0.1% |
| XUHL.DE | Xtrackers MSCI USA Health Care UCITS ETF 1C | 61.5% | -6 bp | -0.1% |
| XUHC.DE | Xtrackers MSCI USA Health Care UCITS ETF 1D | 61.4% | -6 bp | +0.2% |
| IUHC.L | iShares S&P 500 Health Care Sector UCITS ETF | 59.9% | -3 bp | +0.5% |
| IUHE.AS | iShares S&P 500 Health Care Sector UCITS ETF | 59.9% | 0 bp | +0.5% |
| XDG3.DE | Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 42.7% | +17 bp | -0.5% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 29.8% | +22 bp | -4.1% |
Risk and Returns: WHCS.AS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.6%
ALTAR SCORE™
77th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 579 funds in the Global Equity category with an average
ALTAR Score™ of 4.6% and a standard deviation
of 2.7%. WHCS.AS's ALTAR Score™ is approximately 0.7 standard
deviations above the category average. This places WHCS.AS in the 77th percentile
among funds in the category.
Sell-Side Consensus
$9.03
PRICE TARGET
+20.7%
UPSIDE